Scailyte is a Swiss-based company that develops artificial intelligence (AI) technology for biomedical research, pharmaceutical discovery and precision diagnostics.
Founded in 2017 and spun-off from the Polytechnic School of Zurich (ETH), the Company provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human’s hidden “single-cell” secrets from various technical approach, such as cell-sorting, proteomics or genomics. The performance and clinically-relevant application of Scailyte’s platform ScaiVision have been demonstrated in numerous clinical projects that resulted in patent-pending biomarkers.
Year invested : 2020
Sector : Artificial Intelligence / Healthcare
Website : https://scailyte.com/